Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Current Assets (2021 - 2025)

Historic Current Assets for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $4.7 billion.

  • Roivant Sciences' Current Assets fell 1312.61% to $4.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.7 billion, marking a year-over-year decrease of 1312.61%. This contributed to the annual value of $5.0 billion for FY2025, which is 2572.5% down from last year.
  • Per Roivant Sciences' latest filing, its Current Assets stood at $4.7 billion for Q4 2025, which was down 1312.61% from $4.5 billion recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Current Assets ranged from a high of $6.8 billion in Q4 2023 and a low of $1.6 billion during Q3 2023
  • Its 5-year average for Current Assets is $3.6 billion, with a median of $2.4 billion in 2021.
  • As far as peak fluctuations go, Roivant Sciences' Current Assets plummeted by 3290.2% in 2022, and later skyrocketed by 31347.35% in 2023.
  • Over the past 5 years, Roivant Sciences' Current Assets (Quarter) stood at $2.3 billion in 2021, then decreased by 28.03% to $1.6 billion in 2022, then soared by 313.47% to $6.8 billion in 2023, then dropped by 21.2% to $5.4 billion in 2024, then decreased by 13.13% to $4.7 billion in 2025.
  • Its Current Assets stands at $4.7 billion for Q4 2025, versus $4.5 billion for Q3 2025 and $4.6 billion for Q2 2025.